DK
Dinesh Kumar Mani
About Dinesh Kumar Mani
Data last updated:
Dinesh Kumar Mani is a Director at Swaad Pharmaceuticals Private Limited (since 1987). The companies operate in Chemicals. Swaad Pharmaceuticals Private Limited reported revenue of ₹42,819 (FY 2024). Earlier, Dinesh Kumar Mani was a Director at Remiform Healthcare Private Limited (from 2009).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Swaad Pharmaceuticals Private Limited U24234BR1987PTC002752 | Director | 28 Sep 1987 | 1987 | ₹42,819 (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Remiform Healthcare Private Limited U24100HR2009PTC039811 | Director | 14 Dec 2009 | 2009 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Dinesh Kumar Mani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ravish Mani | 02811413 | Swaad Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dinesh Kumar Mani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dinesh Kumar Mani
Dinesh Kumar Mani currently holds 1 directorship: Swaad Pharmaceuticals Private Limited (Director, since 28 Sep 1987, revenue ₹42,819 (FY 2024)).
Dinesh Kumar Mani was first appointed on 28 Sep 1987 as Director at Swaad Pharmaceuticals Private Limited. The most recent appointment on record is 14 Dec 2009 at Remiform Healthcare Private Limited.
Dinesh Kumar Mani held 1 earlier board appointment: Remiform Healthcare Private Limited (Director, from 14 Dec 2009).
The current boards of Dinesh Kumar Mani's companies include Ravish Mani (Swaad Pharmaceuticals Private Limited).